Literature DB >> 25814529

Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia.

Kirsten K Ness1, James P DeLany2, Sue C Kaste3, Daniel A Mulrooney4, Ching-Hon Pui4, Wassim Chemaitilly5, Robyn E Karlage1, Jennifer Q Lanctot1, Carrie R Howell1, Lu Lu1, Deo Kumar Srivastava6, Leslie L Robison1, Melissa M Hudson4.   

Abstract

There is limited information on body composition, energy balance, and fitness among survivors of childhood acute lymphoblastic leukemia (ALL), especially those treated without cranial radiation therapy (CRT). This analysis compares these metrics among 365 ALL survivors with a mean age of 28.6 ± 5.9 years (149 treated with and 216 without CRT) and 365 age-, sex-, and race-matched peers. We also report risk factors for outcomes among survivors treated without CRT. Male survivors not exposed to CRT had abnormal body composition when compared with peers (% body fat, 26.2 ± 8.2 vs 22.7 ± 7.1). Survivors without CRT had similar energy balance but had significantly impaired quadriceps strength (-21.9 ± 6.0 Newton-meters [Nm]/kg, 60°/s) and endurance (-11.4 ± 4.6 Nm/kg, 300°/s), exercise capacity (-2.0 ± 2.1 ml/kg per minute), low-back and hamstring flexibility (-4.7 ± 1.6 cm), and dorsiflexion range of motion (-3.1 ± 0.9°) and higher modified total neuropathy scores (+1.6 ± 1.1) than peers. Cumulative asparaginase dose ≥120,000 IU/m(2) was associated with impaired flexibility, vincristine dose ≥39 mg/m(2) with peripheral neuropathy, glucocorticoid (prednisone equivalent) dose ≥8000 mg/m(2) with hand weakness, and intrathecal methotrexate dose ≥225 mg with dorsiflexion weakness. Physical inactivity was associated with hand weakness and decreased exercise capacity. Smoking was associated with peripheral neuropathy. Elimination of CRT from ALL therapy has improved, but not eliminated, body-composition outcomes. Survivors remain at risk for impaired fitness.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2015        PMID: 25814529      PMCID: PMC4447859          DOI: 10.1182/blood-2015-01-621680

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

1.  Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography.

Authors:  W A Kalender
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

2.  Calibration of the Computer Science and Applications, Inc. accelerometer.

Authors:  P S Freedson; E Melanson; J Sirard
Journal:  Med Sci Sports Exerc       Date:  1998-05       Impact factor: 5.411

3.  Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods.

Authors:  M D Jensen; J A Kanaley; L R Roust; P C O'Brien; J S Braun; W L Dunn; H W Wahner
Journal:  Mayo Clin Proc       Date:  1993-09       Impact factor: 7.616

4.  Limitation of ankle range of motion in survivors of acute lymphoblastic leukemia: a cross-sectional study.

Authors:  M J Wright; J M Halton; R D Barr
Journal:  Med Pediatr Oncol       Date:  1999-04

5.  On the generality of the "sit and reach" test: an analysis of flexibility data for an aging population.

Authors:  R J Shephard; M Berridge; W Montelpare
Journal:  Res Q Exerc Sport       Date:  1990-12       Impact factor: 2.500

6.  Radiation dose and in vitro precision in paediatric bone mineral density measurement using dual X-ray absorptiometry.

Authors:  C F Njeh; S B Samat; A Nightingale; E A McNeil; C M Boivin
Journal:  Br J Radiol       Date:  1997-07       Impact factor: 3.039

Review 7.  Radiation exposure in bone mineral density assessment.

Authors:  C F Njeh; T Fuerst; D Hans; G M Blake; H K Genant
Journal:  Appl Radiat Isot       Date:  1999-01       Impact factor: 1.513

8.  Relative dilution spaces of 2H- and 18O-labeled water in humans.

Authors:  S B Racette; D A Schoeller; A H Luke; K Shay; J Hnilicka; R F Kushner
Journal:  Am J Physiol       Date:  1994-10

Review 9.  Use of L-asparaginase in childhood ALL.

Authors:  H J Müller; J Boos
Journal:  Crit Rev Oncol Hematol       Date:  1998-08       Impact factor: 6.312

10.  Impaired muscle strength in female adolescents and young adults surviving leukemia in childhood.

Authors:  L Hovi; P Era; J Rautonen; M A Siimes
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

View more
  25 in total

1.  Short and long-term impairments of cardiopulmonary fitness level in previous childhood cancer cases: a systematic review.

Authors:  Vesile Yildiz Kabak; Patrick Calders; Tulin Duger; Jibril Mohammed; Eric van Breda
Journal:  Support Care Cancer       Date:  2018-09-25       Impact factor: 3.603

2.  Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report From the St Jude Lifetime Cohort Study.

Authors:  Tara M Brinkman; Kirsten K Ness; Zhenghong Li; I-Chan Huang; Kevin R Krull; Amar Gajjar; Thomas E Merchant; James L Klosky; Robyn E Partin; Ingrid Tonning Olsson; Frederick Boop; Paul Klimo; Wassim Chemaitilly; Raja B Khan; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Gregory T Armstrong
Journal:  J Clin Oncol       Date:  2018-08-09       Impact factor: 44.544

3.  Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study.

Authors:  Carrie R Howell; Carmen L Wilson; Matthew J Ehrhardt; Robyn E Partin; Sue C Kaste; Jennifer Q Lanctot; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Cancer       Date:  2017-12-04       Impact factor: 6.860

4.  Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic Leukemia.

Authors:  Mitra Varedi; Lu Lu; Carrie R Howell; Robyn E Partin; Melissa M Hudson; Ching-Hon Pui; Kevin R Krull; Leslie L Robison; Kirsten K Ness; Raymond F McKenna
Journal:  J Clin Oncol       Date:  2018-05-29       Impact factor: 44.544

5.  Cardiac autonomic dysfunction in survivors of childhood acute lymphoblastic leukemia: The St. Jude Lifetime Cohort Study.

Authors:  Lindsey Christoffersen; Todd M Gibson; Ching-Hon Pui; Vijaya Joshi; Robyn E Partin; Daniel M Green; Jennifer Q Lanctot; Carrie R Howell; Daniel A Mulrooney; Gregory T Armstrong; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Pediatr Blood Cancer       Date:  2020-05-08       Impact factor: 3.167

6.  The 6-minute walk test is a good predictor of cardiorespiratory fitness in childhood cancer survivors when access to comprehensive testing is limited.

Authors:  David Mizrahi; Joanna E Fardell; Richard J Cohn; Robyn E Partin; Carrie R Howell; Melissa M Hudson; Leslie L Robison; Kirsten K Ness; Jamie McBride; Penelope Field; Claire E Wakefield; David Simar
Journal:  Int J Cancer       Date:  2019-12-17       Impact factor: 7.396

7.  Influence of fitness on health status among survivors of acute lymphoblastic leukemia.

Authors:  Carmen L Wilson; Carrie R Howell; Robyn E Partin; Lu Lu; Sue C Kaste; Daniel A Mulrooney; Ching-Hon Pui; Jennifer Q Lanctot; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Pediatr Blood Cancer       Date:  2018-07-29       Impact factor: 3.167

8.  The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.

Authors:  Daniel A Mulrooney; Geehong Hyun; Kirsten K Ness; Nickhill Bhakta; Ching-Hon Pui; Matthew J Ehrhardt; Kevin R Krull; Deborah B Crom; Wassim Chemaitilly; Deokumar K Srivastava; Mary V Relling; Sima Jeha; Daniel M Green; Yutaka Yasui; Leslie L Robison; Melissa M Hudson
Journal:  Lancet Haematol       Date:  2019-05-08       Impact factor: 18.959

Review 9.  Obesity and Metabolic Syndrome Among Adult Survivors of Childhood Leukemia.

Authors:  Todd M Gibson; Matthew J Ehrhardt; Kirsten K Ness
Journal:  Curr Treat Options Oncol       Date:  2016-04

10.  Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: a systematic review.

Authors:  J Vetsch; C E Wakefield; E G Robertson; T N Trahair; M K Mateos; M Grootenhuis; G M Marshall; R J Cohn; J E Fardell
Journal:  Qual Life Res       Date:  2018-01-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.